Cite
HARVARD Citation
Tomonari, T. et al. (2023). Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma. Hepatology research. 53 (2), pp. 172-178. [Online].